TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32979577

Group type: EXPERIMENTAL
Intervention: valaciclovir treatment for 3 months
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Development of IgG anti-N-methyl-D-aspartate receptor (NMDAR) antibodies
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Previous development of IgG anti-NMDAR
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: CSF NFL levels
Number of subjects: 53
Study: 32652616

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD; 20 mg/kg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD; 20 mg/kg/day) with clobazam (CLB)
Number of subjects: 20
Study: 36083324

Group type: EXPERIMENTAL
Intervention: High-volume injection (HVI) - 50 mL
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo injection - 2 mL (saline and lidocaine)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: High-volume injection (HVI)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 62
Study: 33268417

Group type: EXPERIMENTAL
Intervention: Adolescent transition package (ATP) implemented in 10 HIV clinics, including provider tools for disclosure and transition, with training for healthcare providers and continuous quality improvement for 6 months, followed by 1 year of implementation.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard of care provided in 10 control clinics.
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Adolescent transition package (ATP) implemented in 10 HIV clinics.
Number of subjects: 200
Study: 33487095

Group type: EXPERIMENTAL
Intervention: Electronic stimulation (ES) administered to bilateral lower legs using tapping mode (3 Hz)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham group (no active stimulation)
Number of subjects: 46
Study: 33929040

Group type: EXPERIMENTAL
Intervention: Wagyu‐Cross meat
Number of subjects: 34

Group type: COMPARATOR
Intervention: Commercial meat
Number of subjects: 34
Study: 34890373

Group type: EXPERIMENTAL
Intervention: Darvadstrocel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (saline solution)
Number of subjects: 40
Study: 34051006

Group type: EXPERIMENTAL
Intervention: 50 µl Receptal solution
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 100 µl Receptal solution
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 150 µl Receptal solution
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 96
Study: 32601101

Group type: EXPERIMENTAL
Intervention: Colon capsule endoscopy (CCE) as a filter test prior to faecal immunochemical test (FIT)
Number of subjects: 124214

Group type: COMPARATOR
Intervention: Standard screening procedures (Control group)
Number of subjects: 124214
Study: 33895547

Group type: EXPERIMENTAL
Intervention: internet‐delivered cognitive behavioral treatment that included exposure (ICBT)
Number of subjects: 309

Group type: COMPARATOR
Intervention: internet‐delivered cognitive behavioral treatment without exposure (ICBT‐WE)
Number of subjects: 309
Study: 35696698

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg capsules
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo capsules (Becosules)
Number of subjects: 60
Study: 33497135

Group type: EXPERIMENTAL
Intervention: Vitamin D3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strength training exercise program
Number of subjects: 0
Study: 32248747

Group type: EXPERIMENTAL
Intervention: JNJ-54175446 (50-450 mg)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: JNJ-54175446 (≥100 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 35315072

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (livelihood and life skills training, mentoring, health facilities' strengthening)
Number of subjects: 1933

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 1933

Group type: COMPARATOR
Intervention: Control (government cash transfer program)
Number of subjects: 1933
Study: 34627490

Group type: EXPERIMENTAL
Intervention: De-escalation (clopidogrel plus aspirin)
Number of subjects: 2697

Group type: COMPARATOR
Intervention: Active control (ticagrelor plus aspirin)
Number of subjects: 2697
Study: 32762271

Group type: EXPERIMENTAL
Intervention: ibrutinib plus bendamustine plus rituximab (BR)
Number of subjects: 578

Group type: COMPARATOR
Intervention: placebo plus bendamustine plus rituximab (BR)
Number of subjects: 578
Study: 35296491

Group type: EXPERIMENTAL
Intervention: Multinutrient supplement including vitamin D, tryptophan, long‐chain polyunsaturated fatty acids, and prebiotic dietary fibres (94 kCal per daily dose)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Isocaloric isonitrogenous placebo
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Multinutrient supplement
Number of subjects: 166
Study: 33214158

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study: 34633885

Group type: EXPERIMENTAL
Intervention: Cruciate-retaining (CR) tibial component
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Medial congruent (MC) tibial component
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both CR and MC groups
Number of subjects: 60
Study: 33639894

Group type: EXPERIMENTAL
Intervention: Parent-Infant Psychotherapy (PIP) for 6 weeks
Number of subjects: 160

Group type: COMPARATOR
Intervention: Care as Usual (CAU) for 6 weeks
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Parent-Infant Psychotherapy (PIP)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 160
Study: 33668732

Group type: EXPERIMENTAL
Intervention: Habitual smartphone use
Number of subjects: 2298

Group type: EXPERIMENTAL
Intervention: Prebedtime exposure
Number of subjects: 2298
Study: 32417629

Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg (two capsules of 5 mg each) once a day, 1 hour before bedtime for 12 weeks
Number of subjects: 60
Study: 34298274

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention (group A, n=49)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (group B, n=48)
Number of subjects: 97
Study: 32470942

Group type: EXPERIMENTAL
Intervention: Posterior spinal instrumentation and fusion surgery
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Predictive model for height gain
Number of subjects: 116
Study: 35668528

Group type: EXPERIMENTAL
Intervention: Ruxolitinib combined with 1 mg/kg methylprednisolone
Number of subjects: 198

Group type: COMPARATOR
Intervention: 2 mg/kg methylprednisolone alone
Number of subjects: 198
Study: 32543247

Group type: EXPERIMENTAL
Intervention: Enoxaparin (0.75 mg/kg intra-arterial bolus followed by 0.75 mg/kg/6 hours intravenous infusion)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard-of-care (SOC) with unfractionated heparin ± glycoprotein IIb/IIIa antagonist (GPI)
Number of subjects: 100
Study: 35718862

Group type: EXPERIMENTAL
Intervention: Weight-management (diet)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Weight-management-Plus-Exercise (diet-exercise)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control
Number of subjects: 107
Study: 33337731

Group type: EXPERIMENTAL
Intervention: Instructional video
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no video)
Number of subjects: 120
Study: 33258423

Group type: EXPERIMENTAL
Intervention: 1×10^5/ml spore suspension
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sterile water (control)
Number of subjects: 12
Study: 35621321

Group type: EXPERIMENTAL
Intervention: 10% chance of a big prize (10% + B)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 50% chance of a medium prize (50% + M)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 100% chance of a small prize (100% + S)
Number of subjects: 66
Study: 32706635

Group type: EXPERIMENTAL
Intervention: PEGPH20 plus nab-paclitaxel/gemcitabine (AG)
Number of subjects: 494

Group type: COMPARATOR
Intervention: Placebo plus nab-paclitaxel/gemcitabine (AG)
Number of subjects: 494
Study: 35873761

Group type: EXPERIMENTAL
Intervention: Electroacupuncture intervention for 30 min once every 12 h, a total of three times
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Electroacupuncture intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no acupuncture treatment and ASD)
Number of subjects: 60
Study: 33827963

Group type: EXPERIMENTAL
Intervention: IV infusion of human adrenomedullin (19.9 pmol/kg/min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study: 35229627

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) the day before surgery (Group Pre, n = 103)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) 30 min before surgery (Group 30, n = 104)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) both the day before and 30 min before surgery (Group Comb, n = 103)
Number of subjects: 413

Group type: COMPARATOR
Intervention: Usual care alone (Group Usual, n = 103)
Number of subjects: 413
Study: 34747202

Group type: EXPERIMENTAL
Intervention: Whey Protein Hydrolysate (WPH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whey Protein Concentrate (WPC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fasted training
Number of subjects: 0
Study: 34952305

Group type: EXPERIMENTAL
Intervention: Training plus support
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Training only
Number of subjects: 33

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 33
Study: 36401384

Group type: EXPERIMENTAL
Intervention: Endoscopic band ligation (EBL) with large‐volume ligators
Number of subjects: 158

Group type: COMPARATOR
Intervention: Endoscopic variceal obturation (EVO) with tissue glue injection
Number of subjects: 158
Study: 32574223

Group type: EXPERIMENTAL
Intervention: NO3- rich beverage
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 35857179

Group type: EXPERIMENTAL
Intervention: Tralokinumab 300 mg subcutaneous every 2 weeks (q2w) plus topical corticosteroids (TCS) as needed
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo plus topical corticosteroids (TCS) as needed
Number of subjects: 252
Study: 33629887

Group type: EXPERIMENTAL
Intervention: Medialized dome type (dome group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Medialized anatomic type (anatomic group)
Number of subjects: 48
Study: 32453190

Group type: EXPERIMENTAL
Intervention: 0.5-millisecond pulse width ECT
Number of subjects: 312

Group type: COMPARATOR
Intervention: Broader brief width stimulus ECT
Number of subjects: 312

Group type: COMPARATOR
Intervention: >0.5 millisecond pulse width ECT
Number of subjects: 312
Study: 34906924

Group type: EXPERIMENTAL
Intervention: Mobile app-based self-management DTx with regular follow-up
Number of subjects: 290

Group type: COMPARATOR
Intervention: Conventional hospital-based follow-up care
Number of subjects: 290
Study: 34371870

Group type: EXPERIMENTAL
Intervention: 2.6 g marine n‐3 PUFA supplement
Number of subjects: 132

Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 132
Study: 32666291

Group type: EXPERIMENTAL
Intervention: Microdebrider adenoidectomy
Number of subjects: 126

Group type: COMPARATOR
Intervention: Curettage adenoidectomy
Number of subjects: 126
Study: 35012809

Group type: EXPERIMENTAL
Intervention: Colloid group (6% hydroxyethyl starch 130/0.4 10 mL/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Crystalloid group (balanced crystalloid solution, Plasma Solution A 10 mL/kg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Colloid group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Crystalloid group
Number of subjects: 100
Study: 34129541

Group type: EXPERIMENTAL
Intervention: SA without a tourniquet (NT/SA)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: SA with a tourniquet (T/SA)
Number of subjects: 404

Group type: COMPARATOR
Intervention: GA without a tourniquet (NT/GA)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: GA with a tourniquet (T/GA)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: SA group
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: T/SA group
Number of subjects: 404
Study: 32883018

Group type: EXPERIMENTAL
Intervention: Digital training alone (DGT)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Digital training with remote support (DGT+)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Conventional face-to-face training
Number of subjects: 42
Study: 33656123

Group type: EXPERIMENTAL
Intervention: Diabetes (1999)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Diabetes (2012)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Hypertension (1999)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Hypertension (2012)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Smoking and alcohol use
Number of subjects: 488
Study: 32357940

Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS (900 or 1800 pulses per day for 8, 12, or 16 stimulation days)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 258
Study: 36261423

Group type: EXPERIMENTAL
Intervention: Fecal transplant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-fecal transplant stool
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microbial taxa associated with post-fecal transplant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Differentially expressed genes
Number of subjects: 0
Study: 34032718

Group type: EXPERIMENTAL
Intervention: Cycle ergometer exercise (CE)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Qigong exercise (QE)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Comparison between QE and CE
Number of subjects: 26
Study: 36387986

Group type: EXPERIMENTAL
Intervention: (poly)phenol-rich supplement 1,200 mg/day + hypocaloric diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo + hypocaloric diet
Number of subjects: 40
Study: 32335900

Group type: EXPERIMENTAL
Intervention: Powered air‐purifying respirators
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Standard air‐purifying respirators
Number of subjects: 25

Group type: COMPARATOR
Intervention: Unprotected (control)
Number of subjects: 25
Study: 35576997

Group type: EXPERIMENTAL
Intervention: Creative Arts Therapy (CAT) program
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 146
Study: 33080343

Group type: EXPERIMENTAL
Intervention: Traditional statistical tests used for assessing baseline comparability
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Post hoc standardised mean differences (SMDs) calculation
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Claim of baseline comparability
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Lack of reporting on balance assessment
Number of subjects: 142
Study: 33105308

Group type: EXPERIMENTAL
Intervention: 1 g of TXA bolus/1 g of TXA infusion (bolus maintenance)
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: 2 g of TXA bolus/placebo infusion (bolus only)
Number of subjects: 966

Group type: COMPARATOR
Intervention: Placebo bolus/placebo infusion (placebo)
Number of subjects: 966
Study: 33605416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94

Group type: COMPARATOR
Intervention: Perindopril
Number of subjects: 94

Group type: COMPARATOR
Intervention: Bisoprolol
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 94
Study: 34619312

Group type: EXPERIMENTAL
Intervention: Allele 'G' of rs58379944 and rs11574012; Allele 'A' of rs12581281
Number of subjects: 1498
Study: 33557269

Group type: EXPERIMENTAL
Intervention: Context-based approach
Number of subjects: 397

Group type: COMPARATOR
Intervention: Retrieval cue approach
Number of subjects: 397

Group type: COMPARATOR
Intervention: Baseline approach
Number of subjects: 397
Study: 33164724

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 0
Study: 35485346

Group type: EXPERIMENTAL
Intervention: Single doses of JNJ-64530440 (up to 4000 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Multiple doses of JNJ-64530440 (750 mg once daily and 2000 mg for 7 days)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Single and multiple doses of JNJ-64530440
Number of subjects: 10
Study: 33043638

Group type: EXPERIMENTAL
Intervention: Awareness, Courage, and Love (ACL) intervention, 2-hour online group session
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (watched a movie)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups assessed using instruments measuring couple's relationship
Number of subjects: 31
Study: 34840276

Group type: EXPERIMENTAL
Intervention: Solid Ankle Foot Orthosis (AFO) with regular physical therapy for 3 months
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ground Reaction Ankle Foot Orthosis (GRAFO) with regular physical therapy for 3 months
Number of subjects: 30
Study: 32282728

Group type: EXPERIMENTAL
Intervention: Acupuncture (10 sessions of 30 minutes each)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 103
Study: 35157777

Group type: EXPERIMENTAL
Intervention: MUAC only
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: WHZ only
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: MUAC and WHZ
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Underweight and concurrently wasted/stunted
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Low MUAC and low WHZ
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Other indicators (WAZ)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Admissions criteria (WHZ and/or MUAC)
Number of subjects: 301
Study: 32417952

Group type: EXPERIMENTAL
Intervention: Remote patient monitoring (RPM)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard in-office follow-up (CTL)
Number of subjects: 180
Study: 32043473

Group type: EXPERIMENTAL
Intervention: Prehospital intravenous antibiotics
Number of subjects: 357

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 357
Study: 33220122

Group type: EXPERIMENTAL
Intervention: CM for alcohol (n = 30)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: CM for drugs (n = 27)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: CM for alcohol and drugs (n = 32)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control (incentives for submission of urine samples only, n = 25)
Number of subjects: 114
Study: 32084324

Group type: EXPERIMENTAL
Intervention: One-episode story
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Three-episode story
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Core macrostructure components
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Age progression
Number of subjects: 122
Study: 36339874

Group type: EXPERIMENTAL
Intervention: Humanoid robot intervention (Grace humanoid robot, 8-week, twice a week)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Treatment as usual (active control)
Number of subjects: 74
Study: 34511512

Group type: EXPERIMENTAL
Intervention: Walking faster than preferred speeds (in persons with PD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control participants (age-matched)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Patient-specific walking speeds (in persons with PD)
Number of subjects: 12
Study: 32279101

Group type: EXPERIMENTAL
Intervention: Unenhanced CT texture analysis
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Unenhanced CT texture analysis (validated using LGOCV)
Number of subjects: 109
Study: 32662092

Group type: EXPERIMENTAL
Intervention: sitagliptin 100 mg
Number of subjects: 71

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 71
Study: 32560069

Group type: EXPERIMENTAL
Intervention: Workshop intervention with PE teachers
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Doubling physical education classes (3:20 h of PE/week)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control group (1:40 h of PE/week)
Number of subjects: 1200
Study: 34176367

Group type: EXPERIMENTAL
Intervention: History of Intimate Partner Violence (IPV)
Number of subjects: 152

Group type: COMPARATOR
Intervention: No history of Intimate Partner Violence (IPV)
Number of subjects: 152
Study: 33202093

Group type: EXPERIMENTAL
Intervention: YH12852 0.3, 0.5, 1, 2, or 3 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: YH12852 0.05 or 0.1 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: YH12852 (all doses)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Prucalopride 2 mg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 36158129

Group type: EXPERIMENTAL
Intervention: Hp-infected gastric cancer patients (observation group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non Hp-infected gastric cancer patients (comparison group)
Number of subjects: 100
Study: 32359393

Group type: EXPERIMENTAL
Intervention: Qing Qiao Capsule
Number of subjects: 100

Group type: COMPARATOR
Intervention: Caefaclor capsule (Control)
Number of subjects: 100
Study: 35661157

Group type: EXPERIMENTAL
Intervention: Neoadjuvant ipilimumab 1 mg kg−1 and nivolumab 3 mg kg−1 for 6 weeks
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Therapeutic lymph node dissection (TLND) omitted in patients with MPR
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: TLND only for patients with pathologic partial response (pPR)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: TLND and adjuvant systemic therapy ± synchronous radiotherapy for patients with pathologic non-response (pNR)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Grade 3–4 toxicity within the first 12 weeks
Number of subjects: 99
Study: 33957336

Group type: EXPERIMENTAL
Intervention: Tiagabine (15 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 35001439

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP) administration as a complement to standard treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment plus non-convalescent plasma (control)
Number of subjects: 0